FDA Inspection 1286526 — Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon Group (Ningxia) Pharmaceutical Co., Ltd. on Sep 5, 2025 in Shizuishan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 5, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shizuishan (China)